We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Image: A research team led by Prof. Hsing I-Ming (center), Professor of the Department of Chemical and Biological Engineering at HKUST, has developed TEMPO, a thermodynamically programmed one-pot CRISPR platform for rapid, point-of-care nucleic acid testing. Mr. Wu Xiaolong (third right) and Ms. Li Yanan (first left), PhD students from the Department of Chemical and Biological Engineering, are the co-first authors of this study. (Photo courtesy of HKUST)

Single-Tube CRISPR Test Detects Pathogens and Genetic Variants in 30 Minutes

A new one-pot CRISPR test detects pathogens and genetic variants in 30 minutes with ultra-high sensitivity More...
01 Sep 2026
Image Credit: 123RF

NIH-Funded Study Targets Saliva-Based Long COVID Diagnosis

An AI approach analyzes salivary biomarkers to support long COVID diagnosis and predict risk of persistent symptoms. More...
01 Sep 2026
Image:  About 14.2 million Americans are eligible for annual lung cancer screening, but uptake remains low and LDCT false positives persist; CIZ1B may improve risk stratification and reduce uncertainty (Image Credit: Adobe Stock)

Validated Biomarker Blood Test Detects Early Lung Cancer and Supports Risk Assessment

Cizzle Bio’s CIZ1B ELISA biomarker test detects an early lung cancer-linked protein variant, complementing low-dose CT to clarify indeterminate findings. More...
01 Sep 2026
Image Credit: Adobe Stock

New Journal Addresses Evolving Needs in Clinical and Translational Pathology

A new journal unites AI, spatial multi-omics, and molecular pathology to speed diagnosis and therapy selection. More...
01 Sep 2026
Image Credit: Adobe Stock

Machine Learning Model Uses Routine Lab Tests to Support Heart Failure Classification

An AI approach using 13 routine labs flags HFrEF to prioritize echocardiography and support rule-out triage. More...
01 Sep 2026
Image:  About 14.2 million Americans are eligible for annual lung cancer screening, but uptake remains low and LDCT false positives persist; CIZ1B may improve risk stratification and reduce uncertainty (Image Credit: Adobe Stock)

Validated Biomarker Blood Test Detects Early Lung Cancer and Supports Risk Assessment

Cizzle Bio’s CIZ1B ELISA biomarker test detects an early lung cancer-linked protein variant, complementing low-dose CT to clarify indeterminate findings. More...
01 Sep 2026
Image: Graphical Abstract (Sánchez Milán JA, Mulet M, Font-Alberich M, et al. Extracell Vesicles Circ Nucleic Acids. 2026;. doi:10.20517/evcna.2026.18)

Whole-Blood Extracellular Vesicle Analysis Captures Molecular Signals Missed by Plasma Testing

A new whole-blood method isolates extracellular vesicles, revealing platelet and mitochondrial signals missed in plasma. More...
01 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Automatic CLIA Analyzer
Shine i6000
Electrolyte Analyzer
BKE-B
Copyright © 2000-2026 Globetech Media. All rights reserved.